Roche Diagnostics announces FDA clearance with CLIA waiver for its molecular point-of-care test for the detection of Bordetella infections, including whooping cough (pertussis). The cobas liat Bordetella test delivers PCR results in 15 minutes at the point of care. Access to a rapid turnaround helps healthcare providers act quickly to prevent severe complications and onward transmission.